POLH and cancer: The exact clinical implications of the human germline dysfunctional POLH variants remain unclear and further evaluation of in vivo outcomes of these and other undetermined POLH variants would allow a better understanding of the role of POLH variants in interindividual variability in cancer risks and platinum drug responses.